13F HOLDINGS REPORT
Velan Capital Investment Management LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001848809-24-000007
Total Value
$174.6M
Positions
18
Other Managers
0
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ALIMERA SCIENCES INC | 016259202 | 13,608,533 | $75.7M | 43.35% |
| 2 | JASPER THERAPEUTICS INC | JSPRW | 1,188,500 | $27.0M | 15.46% |
| 3 | HERON THERAPEUTICS INC | HRTX | 6,986,744 | $24.5M | 14.01% |
| 4 | PRAXIS PRECISION MEDICINES I | PRAX | 350,666 | $14.5M | 8.31% |
| 5 | JASPER THERAPEUTICS INC | JSPRW | 283,404 | $5.6M | 3.19% |
| 6 | TOURMALINE BIO INC | 89157D105 | 319,080 | $4.1M | 2.35% |
| 7 | TELA BIO INC | TELA | 746,087 | $3.5M | 2.01% |
| 8 | REZOLUTE INC | RZLT | 800,000 | $3.4M | 1.97% |
| 9 | SKYE BIOSCIENCE INC | SKYE | 422,142 | $3.4M | 1.94% |
| 10 | OPTINOSE INC | 68404V100 | 2,492,830 | $2.6M | 1.49% |
| 11 | CONTEXT THERAPEUTICS INC | CNTX | 1,290,323 | $2.6M | 1.48% |
| 12 | INSPIREMD INC | NSPR | 904,029 | $2.3M | 1.29% |
| 13 | OUTLOOK THERAPEUTICS INC | OTLK | 247,084 | $1.8M | 1.04% |
| 14 | ELEVATION ONCOLOGY INC | 28623U101 | 597,299 | $1.6M | 0.92% |
| 15 | PROTARA THERAPEUTICS INC | TARA | 480,000 | $998,400 | 0.57% |
| 16 | KIORA PHARMACEUTICALS INC | KPHMW | 122,223 | $513,337 | 0.29% |
| 17 | X4 PHARMACEUTICALS INC | XFOR | 659,020 | $382,232 | 0.22% |
| 18 | ASLAN PHARMACEUTICALS LTD | 04522R200 | 625,000 | $187,500 | 0.11% |